证券代码： 300194 证券简称：福安药业 福安药业(集团)股份有限公司投资者关系活动记录表 编号：2025-01 投资者关系活动 类别 □特定对象调研 □ 分析师会议 □ 媒体采访 √ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 （请文字说明其他活动内容） 参与单位名称及 人员姓名 投资者网上提问 时间 2025 年 5 月 9 日 (周五) 下午 15:00~17:00 地点 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） 采用网络远程的方式召开业绩说明会 上市公司接待人 员姓名 1、董事长汪天祥 2、董秘汤沁 3、财务负责人余雪松 4、独立董事陈耿 投资者关系活动 主要内容介绍 投资者提出的问题及公司回复情况 公司就投资者在本次说明会中提出的问题进行了回复，主要问题 问答情况如下： 1、6.23 亿是已经计提过了，并不是你所谓的 3.18 亿元。在 2021 年年报里，这个项目最大的一笔计提是所谓的无形资产 6.172 亿元，这个无形资产明显高于 5.03 亿元，你作为财务 负责人不会不知道吧，这个是不是转移资产，洗钱的行为？ 你好，美国被投资公司投 ...

证券代码：300877 证券简称：金春股份 安徽金春无纺布股份有限公司 投资者关系活动记录表 编号：2025-001 | 投资者关系活 | □特定对象调研 □分析师会议 | | --- | --- | | 动类别 | □媒体采访 ☑业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场调研 □其他 | | 参与单位名称 | 全景网"投资者关系互动平台"参与金春股份 2024 年度业绩说明会的 | | 及人员姓名 | 投资者。 | | 时间 | 2025 年 5 月 9 日下午 15：00-16：00 | | 地点 | 全景网"投资者关系互动平台"（https://rs.p5w.net） | | 上市公司 | 董事、总经理：胡俊 | | 接待人员姓名 | 董事、副总经理、董事会秘书、财务总监：仰宗勇 | | | 独立董事：袁帅 | | | 公司于 2025 年 5 月 9 日 15:00—16:00，通过全景网"投资者关 | | | 系互动平台"（https://rs.p5w.net）采用网络远程文字交流形式举办 | | | 2024 年度公司业绩说明会，投资者对公司生产经营、业绩情况等方面 | ...

证券代码：300957 证券简称：贝泰妮 云南贝泰妮生物科技集团股份有限公司 投资者关系活动记录表 | 题，是因为不够重视么还是因为其他？ | | | | --- | --- | --- | | A: 尊敬的投资人您好，感谢您的提问，关于替换芯的问题， | | | | 我们也收到了很多反馈。这也是我们第一次在核心品上做替 | | | | 换芯的尝试。出发点还是希望能够从降低塑料，环保的角度 | | | | 来给用户更好的体验。谢谢您对薇诺娜和贝泰妮的关注和信 | | | | 任。 | | | | Q: 郭总您好，作为薇诺娜的忠实用户和公司投资者，公司产 | | | | 品力没有问题，但售后真的一言难尽，举个例子：小红书上 | | | | 有用了很多年的老用户反应商品没到期但是发生了质变没 | | | | 法用，客服都是很官方的回答，一点人性化的服务都没有， | | | | 让人很寒心，一般多年的老用户是不会故意找麻烦的，丢掉 | | | | 一个老用户很简单，但发展一个用户却很难，希望公司的售 | | | | 后能跟对待自己的员工，对产品质量一样能打，成为一家伟 | | | | 大的公司. | | | | A ...

Group 1: Industry Outlook and Strategic Positioning - The company focuses on grass seed technology innovation and ecological restoration, aligning with national strategies such as the "Three North" project, which aims to combat desertification and improve ecological conditions [1][3][4]. - The grass seed industry is entering a strategic opportunity period due to supportive national policies and increasing market demand, with significant investments made in R&D over the past 20 years [2][5]. - The company is the only listed entity in Inner Mongolia engaged in ecological restoration, positioning it to benefit from historical development opportunities in this sector [4][6]. Group 2: Financial Performance and Growth Drivers - In Q1 2025, the company reported a 28.15% year-on-year increase in revenue, although it still faced a net loss of 16.93 million yuan, indicating challenges in profitability despite revenue growth [6][8]. - The company has won over 80 ecological restoration projects in 2024, with a total value exceeding 2 billion yuan, which is expected to contribute positively to its performance in 2025 [6][7]. - The company emphasizes the importance of credit risk management and has implemented measures to reduce credit impairment losses, which significantly impacted its 2024 performance [7][8]. Group 3: Competitive Advantages and Market Position - The company has established a comprehensive industry chain service system that integrates seed resource protection, breeding, and ecological technology output, enhancing its competitive edge [4][5]. - It has developed a unique ecological restoration model that combines local seed sources with ecological big data, setting it apart from other companies in the sector [4][5]. - The company is actively participating in major ecological projects, leveraging its expertise in arid and semi-arid regions to address challenges such as soil salinization and desertification [4][5][6]. Group 4: Future Prospects and Strategic Initiatives - The company is optimistic about capturing industry growth opportunities and aims to achieve rapid and stable development, with a focus on technological innovation in the grass seed sector [5][8]. - It plans to continue participating in the "Three North" project and other significant ecological initiatives, which are expected to expand its market presence and operational scale [5][6]. - The management is committed to improving financial health by enhancing cash flow management and reducing reliance on credit, with a historical cash flow net inflow of 1.578 billion yuan in 2024 [7][8].

Group 1: Business Focus and Development - The company will focus on four main directions: industry, stock, insurance, and overseas expansion, with key industries being telecommunications, chain operations, new energy, and biomedicine [2][3] - In Q1 2025, new orders signed amounted to approximately CNY 180 million, representing a year-on-year growth of over 20%, with total orders on hand reaching about CNY 500 million by April 30, 2025 [3] Group 2: Insurance Business Progress - The company is developing insurance products such as IDI (Engineering Quality Defect Insurance), comprehensive housing insurance, and safety insurance for small projects, with premium sources being government subsidies and developers [3][4] - The company has achieved a market share of approximately 80% in the South China region, with new orders from other regions increasing to about 40% in Q1 2025 [4] Group 3: Overseas Expansion and Strategic Initiatives - The company has initiated overseas projects in regions like Africa, Dubai, Malaysia, and Indonesia, providing on-site management and third-party evaluation services [3][4] - The company aims to leverage its wholly-owned subsidiary in Hong Kong to respond to the "Belt and Road" initiative and secure more overseas orders [3] Group 4: Technological Development and Market Positioning - Three models related to risk prediction and defect analysis have been developed and localized in regions such as Hainan, Guizhou, and Sichuan, enhancing service efficiency and quality [5] - The company is actively pursuing opportunities in domestic substitution amid trade tensions, with management conducting overseas research and hiring experienced personnel to improve business capabilities [5]

Financial Performance and Strategies - The company reported a loss in Q1 2025 but aims to turn around through various measures, including expanding external markets and enhancing internal business operations [3] - Operating cash flow increased to 456 million CNY, driven by the recovery of receivables and growth in the marine fishery sales [3] - The company plans to control costs and improve efficiency by reducing general management expenses and non-productive costs [3][16] Market and Competitive Landscape - Over 95% of the company's business is domestic, minimizing the impact of U.S. tariffs [3] - The proton therapy market is growing, with the company facing competition from global suppliers like IBA, which holds over 77% of the market share [6] - The company has a differentiated competitive advantage due to its stable operations, core technology, and ongoing projects that meet customer needs [6] Product Development and Innovation - The company is focusing on high-margin products in the new materials sector, including XLPE and specialized nylon cables [4][6] - Continuous innovation in accelerator technology is essential for maintaining market share, with a consistent 60% market share in electronic accelerators [5] - The company is exploring new applications for its products to drive growth in the accelerator segment [5] Future Outlook and Challenges - The company anticipates that the domestic market for gallium-68 and iodine-123 radiopharmaceuticals will grow, contingent on regulatory approvals [7] - The electronic beam waste treatment business is still in the exploratory phase, with plans to focus on key industries like coal chemical and renewable energy [9] - The proton therapy equipment project is expected to face delays in revenue recognition due to construction timelines and regulatory processes [12] Management and Operational Efficiency - Management acknowledges high administrative costs due to investments in new business areas, which are still in the incubation stage [16] - The company is committed to enhancing operational efficiency and reducing costs while increasing the proportion of high-margin products [16][18]

Industry Outlook - The civil explosives industry is essential for national economic and social development, with a promising future driven by policy support and innovation [1][2] - The industry is expected to see increased concentration, with 3-5 large enterprises gaining international competitiveness by 2027 [2][26] Company Strategy - The company aims to enhance profitability through continuous development of major clients and projects, focusing on regions like Inner Mongolia, Sichuan, and Xinjiang [3][4] - Plans to strengthen internal collaboration and optimize regional capacity allocation are in place to improve operational efficiency [3][4] - The company is committed to international expansion, aligning with national policies like the Belt and Road Initiative [3][19] Financial Performance - In 2024, the company achieved a revenue of CNY 9.481 billion, a year-on-year increase of 6.59%, and a net profit of CNY 891 million, up 15.26% [5][19] - The international business has seen significant growth, with overseas revenue surpassing CNY 1 billion, accounting for 10.79% of total revenue [19] Research and Development - The company has increased R&D investment, with expenses reaching CNY 301 million in 2024, representing 3.18% of revenue [21][22] - Collaborations with universities have led to award-winning projects, enhancing the company's technological capabilities [4][21] Market Position - The company maintains a competitive pricing strategy in various provinces, ensuring alignment with market principles [10][11] - The company’s logistics capabilities include over 400 specialized vehicles, with an annual transport capacity exceeding 1.2 million tons [13][14] Risk Management - The company actively monitors international economic conditions and adjusts strategies to mitigate risks associated with tariffs and market fluctuations [5][6] - Measures are in place to manage raw material costs, particularly ammonium nitrate, which is sensitive to commodity price cycles [16][22] Corporate Governance - The company emphasizes market value management, focusing on operational excellence and investor relations to enhance shareholder value [12][15] - The company is committed to sustainable practices, investing in green technologies and achieving recognition as a green factory [27][28]

投资者关系活动记录表 在2025年华为中国合作伙伴大会，公司荣获华为"2024年度卓越ISV 合作奖"及"优选级ICT服务解决方案伙伴"；在2025年华为北京政企合 作伙伴大会，公司斩获"2024年勇攀高峰奖-北京5亿元俱乐部"、"产 业卓越贡献奖-华为云Stack"、"行业卓越贡献奖-金融行业奖"三项奖 项，完成"华为北京政企2025年经销商BP签署计划"，进一步深化同华 为的合作关系。 公司与华为签署了鸿蒙生态合作协议，双方聚焦HarmonyOS NEXT 在金融业务场景的原生应用开发、兼容适配、生态合作、市场拓展等方 面展开全方位、深层次的合作，共同开创数智金融新未来。目前，公司 不仅是华为开发者联盟的生态市场服务商，还成为了首批鸿蒙开发服务 商，后续也有望伴随华为生态的发展和建设，不断扩展自身业务和版图。 此外，宇信科技还培育储备了一支专业技术过硬的鸿蒙开发技术人 才队伍，为公司后续更多产品的原生应用开发与适配提供强有力的支撑。 宇信科技对外发布鸿蒙HarmonyOS NEXT版移动金融开发平台，为鸿蒙 HarmonyOS的应用开发提供一站式的产品支持，帮助企业快速上线鸿蒙 原生APP金融服务，是公司 ...

Group 1: Company Overview and Market Position - Mike Biotech Co., Ltd. is committed to enhancing investor value and strictly adheres to market value management regulations [2][3]. - The company has established a comprehensive market presence with 11 subsidiary channels and 23 offices, covering over 9,100 medical institutions [18]. Group 2: Financial Performance - In 2024, the company reported a revenue of CNY 2.549 billion and a net profit of CNY 127 million; for Q1 2025, revenue was CNY 510 million with a net profit of CNY 24 million [11][14]. - Cumulative cash dividends since listing amount to CNY 1.214 billion, with a proposed dividend of CNY 63 million for 2024, increasing the payout ratio to 50% of net profit [4]. Group 3: Value Management and Investor Relations - The company has implemented a value management system since March 2024, focusing on compliance and maximizing shareholder interests [3][4]. - From 2024 to Q1 2025, the company conducted over 200 investor interactions and issued four investor relations activity records [5][6]. Group 4: Challenges and Strategic Responses - The company faced a decline in performance due to goodwill impairment losses of CNY 94 million and market adjustments related to procurement policies [14][23]. - The IVD industry is experiencing significant pressure from policy changes, with over 70% of companies reporting revenue declines in 2024 [24]. Group 5: Future Outlook and Growth Strategies - The company aims to increase its overseas market share to 30% by 2030, with a projected overseas sales revenue of CNY 160 million in 2024, a 60% increase year-on-year [19][21]. - R&D investment for 2024 was CNY 419 million, representing 21.91% of revenue from self-developed products, focusing on automation and systematization [24].

证券代码：000061 证券简称：农产品 编号：2025-004 深圳市农产品集团股份有限公司投资者关系活动记录表 | 投资者关系活动类别 | 特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 ☐业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 形式 | 现场 ☐网上 电话会议 | | | 电话会议：峰岚资产、关呈私募、仁桥资产、象舆行投资、友邦 人寿、国泰海通证券、腾辉盛华私募基金、富国基金、华宝基金、 | | 参与单位名称及人员姓名 | 明汯投资、Green Court Capital、工银瑞信基金、创富兆业、东吴 | | | 证券等基金经理、机构分析师、研究员共计 16 名投资者 | | 时间 | 2025 年 5 月 9 日 10:00-11:00 | | 地点 | 深圳市农产品集团股份有限公司董事会秘书办公室 | | 上市公司接待人员姓名 | 江疆 董事会秘书 | | | 董事会办公室专员 谢智恒 | | | 一、公司基本情况介绍 | | 投资者关系活动主要内容 | 公司成立于1989年 ...